Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies. Mol Pharmacol by M Harris et al.
ABBREVIATIONS: TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; AHH, aryl hydrocarbon hydroxylase; EROD, 7-ethoxyresorufin O-deethylase; MCDF,




Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY, 35:729-735
Partial Antagonism of 2 ,3 , 7 , 8-Tetrachlorodibenzo-p-dioxin-.
Mediated Induction of Aryl Hydrocarbon Hydroxylase by 6-
Methyl-i ,3 , 8-trichlorodibenzofuran : Mechanistic Studies
M. HARRIS, T. ZACHAREWSKI, B. ASTROFF, and S. SAFE
Veterinary Physiology and Pharmaco!ogy,Texas A&M University, College Station, Texas 77843
Received November 28, 1988; Accepted February 28, 1989
SUMMARY
6-Methyl-i ,3,8-trichlorodibenzofuran (MCDF) binds with moder-
ate affinity to the aryl hydrocarbon (Ah) receptor protein (4.9 x
1 0-8 M) but is a weak Ah receptor agonist. Cotreatment of male
Long Evans rats with MCDF (50 moI/kg) and a dose of 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) that causes a near-maximal
induction of hepatic microsomal aryl hydrocarbon hydroxylase
and ethoxyresorufin O-deethylase activities resulted in a signifi-
cant inhibition of these activities for up to 96 hr. Comparable
results were obtained with MCDF (1 O M) and TCDD (1 0_8 M) in
rat hepatoma H-4-ll E cells in culture over 36 hr. TCDD treatment
of rats resulted in an initial decrease of hepatic cytosolic Ah
receptor within 6 hr and this was followed by a subsequent
1 38% increase in cytosolic receptor levels 72 hr after treatment.
Although MCDF (50 moI/kg) did not significantly alter rat hepatic
cytosolic Ah receptor levels in animals cotreated with TCDD plus
MCDF, the latter compound significantly inhibited TCDD-me-
diated replenishment of the cytosolic Ah receptor. In contrast,
treatment of rat hepatoma H-4-ll E cells with TCDD (1 0 M)
resulted in the rapid (within 1 hr) depletion of cytosolic Ah
receptor, which remained undetectable for up to 36 hr; cotreat-
ment of the cells with MCDF (1 0 M) and TCDD (1 0_8 M) resulted
in cytosolic Ah receptor levels that were similar to those observed
after treatment with TCDD alone. The effects of MCDF on the
uptake and persistence of nuclear [3HJTCDD-Ah receptor com-
plex levels were also determined in rat liver and rat hepatoma H-
4-Il E cells in culture. MCDF did not significantly decrease levels
of occupied nuclear Ah receptor complexes in the rat or rat
hepatoma cells. Moreover, using the sucrose density gradient
assay procedure, the sedimentation coefficients of the cytosolic
and nuclear TCDD-Ah receptor complexes in the presence or
absence of MCDF were comparable. The results of these and
other related studies with 6-substituted-i ,3,8-tnchlorodibenzo-
furans suggest that MCDF may act as a partial TCDD antagonist
by competing with TCDD for nuclear binding sites.
TCDD elicits diverse tissue-, species-, strain-, and age-spe-
cific biologic and toxic responses in animals and mammalian
cells in culture (reviewed in Refs. 1-4). One response, namely
the induction of cytochrome P-4SOlAi gene expression, has
been extensively investigated at the cellular and molecular level
and the results of these studies have formed the basis for the
proposed mechanism of action of TCDD and related com-
pounds. This mechanism involves the initial binding of TCDD
to a soluble intracellular protein, designated the Ah receptor,
followed by the accumulation of the occupied receptor in the
nuclei of target cells. The subsequent interaction of the occu-
pied Ah receptor complexes with specific nuclear binding sites
or “dioxin regulatory elements,” which are located upstream
from the 5’ end of the cytochrome P-4501A1 gene, is required
for increased gene transcription (4-6).
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Several compounds, including 1 -amino-3,7,8-trichlorodi-
benzo-p-dioxin, 1 ,3,6,8-tetrachlorodibenzofuran, 2,3,6,8-te-
trachlorodibenzofuran, MCDF, Aroclor 1254, and a-naphtho-
flavone antagonize the induction of AHH and EROD enzyme
activities and cytochrome P-450iA1 in both in vivo and in vitro
systems (7-11). All of these chemicals are typically weak Ah
receptor agonists and bind with moderate affinity to the Ah
receptor protein. Previous studies in our laboratory ( 1 1) have
shown that MCDF partially antagonizes the TCDD-mediated
induction of AHH and EROD enzyme activities in rat hepa-
toma H-4-II B cells and rat hepatic microsomes and the induc-
tion of cytochromes P-4501A1 and P-4501A2 in the latter
system. This study investigates the mechanism of the MCDF-
mediated antagonism of the induction of AHH and EROD
activities by TCDD, by measuring the effects of the partial
antagonist on cytosolic Ah receptor levels and their replenish-
ment and on occupied nuclear [H]TCDD receptor complexes.
730 Hams et a!.
Materials and Methods
Chemicals and biochemicals. [3HJTCDD (37 Ci/mmol), MCDF,
ethoxyresorufin, and TCDF have previously been prepared in this
laboratory, as described (11). Benzo[ajpyrene, NADP, NADPH, rho-
damine B, bovine serum albumin, and HEPES were purchased from
Sigma Chemical Co. (St. Louis, MO). Hydroxylapatite was purchased
from Bio-Rad Laboratories (La Jolla, CA). ‘4C-labeled bovine serum
albumin and catalase (prepared in this laboratory) were used as external
standards for determination of sedimentation coefficients (S values).
All other chemicals and biochemicals used in these studies were the
highest quality available commercial products.
In vivo animal treatment and isolation of rat hepatic cytosol.
Immature male Long Evans rats were obtained from Harlan (Houston,
TX). The animals were housed in polycarbonate cages, fed Ralston
Purina rat chow ad Ithitum, and maintained on a daily 12-hr diurnal
light/dark cycle. The animals were sacrificed either by ether anesthesia
or cervical dislocation and were killed at approximately the same time
each day to minimize diurnal differences in hormone levels. The livers
were perfused in situ via the portal vein with HEDGM buffer (25 mM
HEPES, pH 7.4, 15 mM EDTA, 1 mM dithiothreitol, 20 mM molybdate)
and 10%, v/v, glycerol. The blanched livers were placed in HEDGM
buffer and kept on ice. All remaining procedures were carried out at 0-
4’. The livers were finely minced with scissors and rinsed with 2
volumes of buffer. The livers were homogenized to a uniform homoge-
nate using a Teflon-glass Potter-Elvehjem homogenizer. The homoge-
nate was centrifuged at 105,000 x g in a Beckman L8 70 ultracentrifuge
for 60 mm. The supernatant cytosolic fraction was removed and care
was taken to exclude the upper lipid layer. The cytosol was stored in
liquid nitrogen and used within 2 weeks after preparation. The concen-
tration of protein in the cytosol was determined on the day of sacrifice.
On the day of the assay, the cytosol was diluted with HEDGM buffer
(containing freshly added dithiothreitol) and an aliquot of the diluted
protein was used to redetermine protein concentration. This protocol
was used to isolate cytosol from rats treated with TCDD, MCDF, and
TCDD plus MCDF. The levels of Ah receptor in the cytosolic fraction
were determined by measuring the specific binding of [3H]TCDD using
the hydroxylapatite assay, as outlined below.
Isolation of rat hepatic nuclear receptor-ligand complexes.
The rats were injected intraperitoneally with the [3H]TCDD (16 nmol/
kg) and sacrificed at several time points up to 72 hr after initial
treatment. The perfused liver was removed, weighed, and placed in a
beaker containing 5 ml of HEDGM buffer. The liver was then homog-
enized in a 35-ml Wheaton homogenizing tube with a Teflon pestle; 5
passes with the pestle resulted in the highest yield of nuclei as deter-
mined by light microscopy. This homogenate was centrifuged at 1000
x g for 15 mm. The pellet was termed the nuclear fraction and washed
three additional times with HEDGM buffer, each time with a 10-mm
spin at 1000 x g. After the third wash, the nuclear pellet was resus-
pended in HEGDM containing 0.5 M KC1. This homogenate was
subjected to six or seven passes with the Teflon pestle/Wheaton
apparatus. The homogenate was then allowed to incubate for 1 hr at
4’ and was centrifuged at 105,000 x g for 1 hr. The resulting pellet was
used to quantitate total DNA. The supernatant was collected and 1 ml
was treated with 0.01 charcoal/0.001% dextran solution for 15 mm.
The charcoal was removed by centrifugation and 300 zl of this nuclear
extract was placed onto a 5-25% sucrose gradient made in 0.4 M KC1.
The gradient was centrifuged at 435,000 x g for 2.5 hr and fractionated
with an LKB fractionator. Four drops were collected per fraction.
Specific binding of the nuclear fraction was determined by a comparable
experiment using [3H]TCDD and a 200-fold molar excess of unlabeled
TCDD or TCDF. The amount of radioactivity in the specifically bound
peak is utilized to calculate the levels of nuclear receptor complex per
mg of nuclear protein or nuclear DNA. Protein and DNA concentra-
tions were determined by the methods of Lowry et al. (12) and Labarca
and Paigen (13), respectively. This approach can be used to determine
the effects of MCDF (50 smol/kg) on the levels of nuclear [3H]TCDD-
Ah receptor complexes and the rate of decomposition of these com-
plexes in the presence or absence of MCDF.
Rat hepatoma H-4-II E cells: growth and isolation of nuclear
and cytosolic receptors. Mammalian cells (H-4-II E) were grown as
a continuous cell line in minimum essential medium without ribonu-
cleosides, deoxyribonucleosides, and sodium bicarbonate, but with L-
glutamine. The medium was supplemented with 10% fetal calf serum,
10% serum, 50 sg/ml gentamicin sulfate, and 22.5 gg/ml Fungizone.
Stock cultures were grown in 150-cm2 culture flasks in an humidified
air/carbon dioxide (95:5) atmosphere at 37” . After reaching confluency,
the cultures were trypsinized and seeded, in 150-cm2 culture flasks, at
io cells/plate in 50 ml of medium. MCDF (10 M) and/or [3H]TCDD
(108 mM) in dimethylsulfoxide were added to the cell culture flasks
(eight flasks/point) so that the final concentration of dimethylsulfoxide
in the culture medium was 0.5%. Nuclear extract baselines were ob-
tamed by co-administering a 200-fold excess unlabeled TCDF. After
incubation, the medium was removed and the cell surface was rinsed
twice with phosphate-buffered saline (pH 7.4, 0.90% NaC1). The cells
were harvested 48 hr after plating by trypsinization and were pooled in
two 50-ml disposable polypropylene tubes. This and all subsequent
procedures were performed at 4”.
Isolation of cytosolic and nuclear fractions from rat hepa-
toma cells. Harvested cells were washed two times in 30 ml of HEGD
buffer (25 mM HEPES, 1.5 mM EDTA, 1 mM dithiothreitol, and 10%,
v/v, glycerol, pH 7.6) by resuspending the pellet with a disposable
pipette and pelleting the suspension by centrifugation for 10 mm at
100 x g. The washed cell pellet was resuspended in 1.5 ml of HED
buffer (25 mM HEPES, 1.5 mM EDTA, 1 mM dithiothreitol) and was
transferred to a 15-ml Wheaton homogenizing tube. Cells were homog-
enized with five full speedstrokes of a Teflon pestle/drill apparatus.
The homogenate was transferred to a 15-ml disposable polypropylene
tube with an additional 1.5 ml of HEGDM and was centrifuged at 1000
x g for 10 mm. The resulting pellet was used for the preparation of the
nuclear extract. The supernatant fraction was centrifuged at 110,000
x g for 1 hr at 2” to yield the cytosolic fraction. Cytosolic and nuclear
fractions were prepared and analyzed by the sucrose density gradient
procedure on the same day. The 1000 x g pellet resulting from centrif-
ugation of cell homogenates was washed two times, as described above,
with 10 ml of HEGDM. The washed pellet was transferred in 3 ml of
HEGDM buffer that contained 0.5 M KC1, pH 8.5, and was resuspended
using a disposable pipette. The suspension was allowed to stand at 4”
for 1 hr and then centrifuged at 105,000 x g for 1 hr. The resulting
supernatant and pellet were saved for further investigation, as described
above. Microscopic examination of nuclei prepared in this fashion were
found to be intact and appeared to be greater than 90% free of
extranuclear contamination. This assay was used for the time-course
study of the effects of TCDD, MCDF, and TCDD plus MCDF on
cytosolic Ah receptor levels.
Induction of AHH and EROD activities. Microsomes were iso-
lated from rat liver homogenates by differential centrifugation, as
described, and the determinations of AHH and EROD were carried out
on the hepatic microsomes and cell preparations using the methods of
Nebert and Gelboin (14) and Pohl and Fouts (15), respectively. Meas-
urement of the induction of AHH and EROD in the rat hepatoma H-
4-Il E cells utilized the same enzyme assay as previously described
(11).
Statistical analysis. The statistical differences between treatment
groups were determined by the Student t test and the levels of proba-
bility are noted (p < 0.05 orp < 0.01). The data are expressed as means
± standard deviations.
Results
Studies with rat subcellular fractions. Fig. 1 summarizes
the time course of induction of hepatic microsomal AHH and
EROD activities by TCDD (16 nmol/kg) and TCDD plus
MCDF (SO smol/kg). MCDF (SO zmol/kg) alone was inactive
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Fig. 1. Time course of induction of rat hepatic microsomal AHH (A) and
EROD (B) by TCDD (1 6 nmol/kg) and TCDD (i 6 nmol/kg) plus MCDF
(50 tmol/kg). The assay procedures are summarized in Materials and
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Fig. 2. Time course of accumulation of nuclear [3HITCDD Ah receptor
complexes in rats treated with [3H]TCDD (i 6 nmol/kg) and [3H]TCDD
(1 6 nmol/kg) plus MCDF (50 mol/kg). The levels of nuclear receptor
complexes were determined by the sucrose density gradient assay
procedure as described. The data are expressed as means ± standard
deviations. Significant differences in nuclear receptor levels were ob-
served only at the 24- and 48-hr time points.
as an inducer. Maximal induction was observed between 24 and
36 hr after treatment with TCDD and the induction response
persisted for 96 hr. MCDF at a dose of 50 tmol/kg was inactive
as an inducer of the monooxygenase activities and cotreatment
of the rats with MCDF plus TCDD resulted in significantly
lower induction, compared with animals treated with TCDD
alone; the antagonism was observed 24 to 96 hr after cotreat-
ment. Fig. 2 summarizes the time course of accumulation of
occupied [3HJTCDD-Ah receptor complexes in rats treated with
[3H]TCDD alone and [3HITCDD plus MCDF. The levels of
nuclear complexes were comparable in animals treated with
either E3HITCDD or [3HJTCDD plus MCDF after 72 hr; how-
ever, there were significant differences between the groups at
the 24 and 48 hr time points.
The effects of TCDD treatment on hepatic cytosolic receptor
levels (Fig. 3) were comparable to those reported by Sloop and
Lucier (16). After treatment with TCDD, there was an initial
decrease in the cytosolic receptor levels and this was followed
by a time-dependent replenishment of cytosolic Ah receptors;
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Fig. 3. Time course of effects of TCDD (i 6 nmol/kg), MCDF (50 gmol/
kg), and TCDD (i 6 nmol/kg) plus MCDF (50 zmol/kg) on rat hepatic
cytosolic Ah receptor levels using the hydroxylepatite assay procedure
as described. The data are expressed as means ± standard deviations.
after 48-72 hr the cytosolic Ah receptor levels were 38% greater
than those observed in the corn oil (control)-treated animals.
MCDF treatment alone did not cause any major variation in
cytosolic Ah receptor levels, compared with the corn oil-treated
control rats; however, the results illustrated that, in the animals
cotreated with TCDD plus MCDF, the latter compound par-
tially inhibited the TCDD-mediated replenishment of the cy-
tosolic receptor levels. The sedimentation coefficients for the
rat hepatic cytosolic and nuclear receptor complexes are sum-
marized in Fig. 4 and the results were comparable to those
observed for the rat hepatoma H-E-II E Ah receptors. The
sucrose density gradient sedimentation coefficients were iden-
tical in the presence or absence of MCDF.
In vitro studies. Fig. 5 summarizes the time course of
induction of AHH and EROD activities by TCDD (10 M),
MCDF (10 M), and TCDD (10 M) plus MCDF (10 M).
MCDF did not significantly induce AHH or EROD activities
over the 36-hr time course, whereas TCDD caused maximal
induction after 18 hr and these induced levels were maintained
for the duration of the experiment. Cotreatment of the cells
with TCDD plus MCDF resulted in a significant decrease in
the enzyme induction responses, compared with the effects of
treatment with TCDD alone. Significant antagonism of the
monooxygenases was observed after 18 hr and was maintained
for up to 36 hr. Table 1 summarizes the effects of staggered
treatment of the cells with MCDF (10 M). At time 0, all cells
were treated with TCDD (10_8 M) and MCDF was added at
various times before and after the inducer. Significant antago-
nism of the induced monooxygenase enzyme activities by
TCDD was observed when MCDF was added to the media at
any of the time points from 2 hr before to 12 hr after the
addition of TCDD.
Fig. 6 summarizes the time course of accumulation of the
TCDD receptor complex in the nucleus in the presence or
absence of MCDF. In the [3H]TCDD-treated cells, an initial
peak of occupied receptor complex was observed after 2 hr
(approximately 250 fmol of nuclear complex/mg of DNA),
which decreased substantially to 80-100 fmol of nuclear com-
plex/mg of DNA after 4 hr and was then maintained for the
remaining 36-hr treatment period. The effects of MCDF on
nuclear TCDD receptor levels are also summarized in Fig. 6
and it was apparent that MCDF did not cause a significant
decrease in occupied nuclear receptor levels throughout the
total 36-hr incubation period. Fig. 7 illustrates that treatment
-0-- H]TCDD































0 5 10 15 20
I 0 1 5 2 0 2 5 3 0 FRACTION
FRACTION
Fig. 4. Sucrose density gradient analysis of cytosolic Ah receptors from rat liver (top right) and rat hepatoma H-4-Il E cells (top left) and nuclear Ah
receptor complexes extracted from rat liver (bottom right) and rat hepatoma H-4-Il E cells (bottom left). A 200-fold excess of TCDF was used to
determine specific binding and 14C-labeled bovine serum albumin and catalase were used as external standards to determine sedimentation constant
(S).
with either TCDD or TCDD plus MCDF rapidly depleted
cytosolic receptor levels within the first hour after treatment
and these levels remained depressed for the duration of the
study. Fig. 4 illustrates the sucrose density gradient profiles of
the cytosolic and nuclear TCDD receptor complexes from rat
hepatoma H-4-II E cells; their sedimentation coefficients were
9.21 ± 1.01 and 5.46 ± 1.04 5, respectively.
Discussion
MCDF binds with moderate affinity to the Ah receptor and
is a weak Ah receptor agonist in rats and mice (11, 17).
Cotreatment of male rats with a subeffective dose of MCDF
(e.g., 50 smol/kg) plus TCDD (16 nmol/kg) resulted in partial
antagonism of the induction of AHH and EROD activities and
cytochromes P-4501A1 and P-4501A2, compared with the ef-
fects observed after treatment of the rats with TCDD alone
(11). MCDF also partially antagonized TCDD-mediated im-
munotoxicity (inhibition of the splenic plaque-forming cell
response to sheep red blood cells) teratogenitcity (cleft palate),
and AHH induction in C57BL/6J mice (17); however, partial
antagonism of the latter response was less dramatic in mice
than in rats. Double-reciprocal plot analysis of the saturation
binding isotherms obtained with [3H]TCDD in both rat and
mouse hepatic cytosol in the presence of different concentra-
tions of MCDF gave linear plots that intersected on the y-axis,
suggesting that MCDF acts as a competitive inhibitor (11, 17).
Comparable results have been reported for Aroclor 1254, a-
naphthoflavone, and 1 -amino-3,7,8-trichlorodibenzo-p-dioxin
(8-10).
The in vivo time course of induction of rat hepatic microso-
mal AHH and EROD activities by TCDD is summarized in
Fig. 1 and demonstrates that both enzymes are rapidly induced
over a period of 24-36 hr and are maintained at a maximally
induced level for up to 96 hr. This rapid and persistent increase
in enzyme activities by TCDD has previously been noted for
TCDD and related halogenated aryl hydrocarbons (18-20).
Polynuclear aromatic hydrocarbons such as 3-methylcholan-
threne also cause a rapid induction response (18, 19); however,
the induced enzyme activities do not persist, presumably due
to rapid metabolism of the parent hydrocarbons. In contrast,
MCDF (50 zmol/kg) does not significantly induce AHH or
EROD activities over the 96-hr observation period and this was
consistent with previous studies with this compound (11, 17).
Cotreatment of the rats with MCDF plus TCDD resulted in
significant partial antagonism of the induction responses
within 24 hr and the antagonism was maintained for up to 96
hr. These results suggest that, at least over the limited duration
of the in vivo study (i.e. 96 hr), hepatic levels of MCDF are
sufficient to partially antagonize the induction of the monoox-
ygenase activities. This is not surprising, because the 1,3,6,8-
substituted dibenzofuran antagonists are substituted on alter-
nate carbon atoms and, therefore, do not contain adjacent
unsubstituted positions that would facilitate oxidative ring
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Fig. 6. Time course of accumulation of nuclear [3H]TCDD-Ah receptor
complexes in rat hepatoma H-4-ll E cells treated with [3H]TCDD (108 M)
and [3HJTCDD (1 0 M) plus MCDF (1 0 p4 using the sucrose density
gradient assay procedures. The data are expressed as means ± standard
deviations.
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Fig. 5. Time course of induction of AHH (A) and EROD (B) by TCDD
(10 M), MCDF (10 M), and TCDD (10 M) plus MCDF (i0 M) in rat
hepatoma H-4-ll E cells. The results are expressed as means ± standard
deviations.
TABLE 1
Induction of AHH and EROD by TCDD and TCDD plus MCDF: effects
of timing on the partial antagonist activity of MCDF
All enzymes were assayed after 1 8-hr incubation with 1 0 M TCDD (added at time
0).


















138 ± 1 1 .7 245 ± 12.9
141 ± 2.60 246 ± 17.0
127 ± 9.75 223 ± 14.7
101 ± 9#{149}37a169 ± i1.7
87.2 ± 3.70 154 ± 3#{149}75a
75.8 ± 4.15a 131 ± 15.88
67.0 ± 3.718 lii ± 6.018
66.7 ± 5.928 109 ± 2.668
68.7 ± 6.688 125 ± 6.028
62.3 ± 4.528 114 ± 2.728
68.9 ± 3.328 118 ± 6.638
73.4 ± 4338 131 ± 6.318
76.2±2.008 114± 11.08
75.7 ± 2.318 121 ± 7.488
75.0 ± 3.858 105 ± 3.528
TCDD (1 0-8 M)
Control (dimethylsulfoxide)
1 53 ± 8.1 1 264 ± 17.2
0 ± 0 4.63 ± 0.39
aSignificantly different (p< 0.01) from cells treated with TCDD (1 0 M) alone.
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Fig. 7. Time course of effects of TCDD (10 M) and TCDD (1 0_8 M) plus
MCDF (1 0- M) on cytosolic receptor levels in rat hepatoma H-4-ll E cells.
Data are expressed as means ± standard deviations.
activity as an inducer of AHH and EROD enzyme activities
and, in the cotreatment experiments (Fig. 5), MCDF partially
antagonized the induction of both monooxygenases. Partial
antagonism was observed 12 hr after the initial treatment with
TCDD and MCDF and persisted for 36 hr.
Sloop and Lucier (16) first noted that treatment of rats with
TCDD resulted in a persistent elevation of hepatic Ah receptor
levels. In other studies, it has also been reported that TCDD
treatment also decreases cellular levels of other receptors [(e.g.,
progesterone (23, 24), estrogen (23, 24), and epidermal growth
factor [25, 26)]. Fig. 3 illustrates the effects ofTCDD (16 nmol/
kg) on rat hepatic cytosolic Ah receptor levels for 72 hr after
treatment. After an initial rapid decrease in receptor levels over
the first 6 hr, there was a rapid replenishment of the cytosolic
Ah receptor and, compared with the untreated animals, the
receptor levels remained elevated for up to 72 hr. Sucrose
density gradient analysis of hepatic cytosolic Ah receptors from
the control or TCDD-treated rats gave peaks that sedimented
at 9-10 S (see Fig. 4) and this was consistent with S values
that have been previously reported (27-29). It is noteworthy
that in vivo treatment with other Ah receptor agonists such as
$-naphthoflavone (29), and 3,3’,4,4’,5-pentachlorobiphenyl
(30) did not elevate hepatic Ah receptor levels in C57BL/6
mice and Wistar rats, respectively, whereas cytosolic Ah recep-
tor levels were significantly elevated after treatment of rats
with 2,2’,4,4,’,5,5,’-hexachlorobiphenyl (30). Thus, two halo-
genated aryl hydrocarbons, namely TCDD and 2,2’,4,4’,5,5’-
antagonists is ideally suited for more long term in vivo studies
and this was confirmed by the results shown in Fig. 1. Not
surprisingly (11), the results from the in vitro studies in rat
hepatoma H-4-II E cells were comparable to those observed in
the rat; MCDF (i0 M) exhibited minimal Ah receptor agonist
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hexachlorobiphenyl, both elevated hepatic Ah receptor levels
in rats; however, only TCDD was an Ah receptor agonist.
The results summarized in Fig. 3 also show that MCDF
treatment does not significantly alter hepatic cytosolic Ah
receptor levels in rats; however, in the cotreatment studies
(TCDD plus MCDF), it was evident that MCDF significantly
inhibited TCDD-mediated replenishment of the cytosolic re-
ceptor. It is possible that TCDD-induced elevation of hepatic
Ah receptor levels may represent another Ah receptor-mediated
process that is also partially antagonized by MCDF. Previous
studies on the interactions of estradiol and partial estrogen
antagonists have reported similar results and it was suggested
that inhibition of cytosolic receptor replenishment may play a
role in the activity of an antagonist (31). The biological impor-
tance of cytosolic Ah receptor replenishment and the inhibition
of this process by MCDF is unknown and further studies are
required to determine the significance of these observations.
The effects of TCDD and TCDD plus MCDF on cytosolic
Ah receptor levels in rat hepatoma H-4-II E cells (Fig. 3)
contrasted dramatically with the observed in vivo data (i.e., Fig.
3). Within 1 hr after treatment with either TCDD or TCDD
plus MCDF, cytosolic Ah receptor levels rapidly decreased to
nondetectable levels and remained depressed for up to 36 hr.
Thus, the mechanisms associated with cytosolic Ah receptor
replenishment observed in rats are not functional in the cells
and constitute a major difference between the two systems.
The observation that TCDD causes a rapid decrease in
apparent cytosolic Ah receptor in the rat hepatoma H-4-II E
cells was utilized in a study that investigated the importance
of measurable cytosolic receptor levels and timing in the action
of MCDF as an antagonist (Table 1). Treatment of the cells
for 18 hr with TCDD (i0 M) resulted in the induction of AHH
and EROD activities. As noted previously (Fig. 5), simultaneous
cotreatment of the cells with TCDD plus MCDF (10 M)
resulted in significant partial antagonism of the enzyme induc-
tion responses. Moreover, significant partial antagonism by
MCDF was observed when the compound was added to the
cells 2 and 1 hr before treatment with TCDD or 0.25, 0.5, 1, 2,
4, 6, and 12 hr after treatment with TCDD. These results show
that, in the absence of measurable cytosolic Ah receptor (i.e.,
after 1 hr), the activity of MCDF as a partial antagonist was
retained. However, based on the measured levels of cytosolic
Ah receptor in this study, there are approximately 1600 Ah
receptor binding sites/cell. In contrast, if the observed nuclear
Ah receptor complex levels are used for the calculation, there
are approximately 4200 Ah receptor binding sites/cell. These
results suggest that there may be cellular reservoirs of Ah
receptor that are available for interaction with MCDF after the
apparent TCDD-mediated depletion of cytosolic Ah receptors.
Thus, these results do not preclude the possibility that MCDF
may act as a partial antagonist via binding to the Ah receptor;
however, the reasons for the low partial antagonist activities
observed when MCDF is added before TCDD have not been
determined. The role of the Ah receptor in this process is
supported by results obtained for a series of 6-substituted-1,3,8-
trichlorodibenzofurans (32), in which only those congeners that
exhibited moderate affinity for the Ah receptor protein and
contained linear alkyl substituents (i.e., methyl, ethyl, propyl,
isopropyl, and t-butyl) exhibited partial antagonist activity. In
contrast, the 6-cyclohexyl analog was a poor Ah receptor bind-
ing ligand and exhibited no activity as an antagonist of TCDD-
mediated AHH/EROD induction in rats or rat hepatoma H-4-
II E cells.
Fig. 2 summarizes the levels of hepatic nuclear [3HJTCDD
Ah receptor complexes in rats treated with [3HITCDD (16
nmol/kg) and [3HJTCDD (16 nmol/kg) plus MCDF (50 mol/
kg). With the exception of one time point, namely 24 hr, there
were no significant differences in the levels of occupied nuclear
receptor complexes in the presence or absence of MCDF. More-
over, if the receptor levels after 24 hr are calculated in terms
of fmol of receptor complex/mg of nuclear protein (data not
shown), there were no significant differences in occupied nu-
clear [3H]TCDD Ah receptor complexes in the presence or
absence of MCDF. The in vitro results summarized in Fig. 6
also showed that the levels of hepatic nuclear [3H]TCDD Ah
receptor complexes were not significantly different in the pres-
ence or absence of MCDF. Previous studies of genetically
inbred mice by Tukey and co-workers (20) have reported a
correlation between the levels of nuclear [3H]TCDD receptor
complex and the percentage of maximally induced cytochrome
P-4501A1 mRNA, which also correlated with the per cent
induction of cytochrome P-4501A1 and dependent enyzme ac-
tivities. The results obtained in this study and in previous work
(11) clearly show that MCDF can reduce the TCDD-mediated
induction of AHH and EROD activities in rat liver and rat
hepatoma H-4-II cells; however, the occupied nuclear levels are
not significantly altered after cotreatment with the partial
antagonist. Moreover, the sucrose density gradient sedimenta-
tion coefficients for nuclear [3H]TCDD-Ah receptor complexes
(5-6 S from rat liver or rat hepatoma H-4-II E cells) were
comparable in the presence or absence of MCDF (Fig. 4). These
data can be interpreted in several ways; however, based on the
results presented herein and on related studies (7, 8, 11, 17,
30), it is hypothesized that the antagonist activity of MCDF is
associated with initial formation of an Ah receptor complex,
followed by competition for nuclear binding sites, which may
include the dioxin regulatory elements located in the 5’-up-
stream region for the cytochrome P-4501A1 gene (4-6). Current
research is focused on the preparation of radiolabeled analogs
of MCDF that can be utilized to further probe the cellular
interactions of the partial antagonist with the Ah receptor (or
other proteins) and the disposition of the compound/complex
in target cells.
References
1. Poland, A. W., W. F. Greenlee, and A. S. Kende. Studies on the mechanism
of action of the chlorinated dibenzo-p-dioxins and related compounds. Ann.
N. Y. Acad. Sci. 320:214-230 (1979).
2. Poland, A., and J. C. Knutson. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and re-
lated halogenated aromatic hydrocarbons: examination of the mechanism of
toxicity. Annu. Rev. PharmacoL Toxicol. 22:517-554 (1982).
3. Safe, S. H. Comparative toxicology and mechanism of action of polychlori-
dated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Phormacol. Toxicol.
26:371-399 (1986).
4. Whitlock, J. P. The regulation of gene expression by 2,3,7,8-tetrachlorodi-
benzo-p-dioxin. PharmacoL Rev. 39: 147-161 (1987).
5. Whitlock, J. P. The regulation of cytochrome P-450 gene expression. Annu.
Rev. Pharmacol. Toxicol. 26:333-369 (1986).
6. Gonzalez, F. J., and D. W. Hebert. P-450 genes: structure evolution and
regulation. Annu. Rev. Biochem. 56:945-993 (1987).
7. Keyes, B., J. Piskorska-Pliszczynska, and S. Safe. Polychlorinated dibenzo-
furans as 2,3,7,8-TCDD antagonists: in vitro inhibition of monooxygenase
induction. Toxicol. Lett. 3 1 :151-158 (1986).
8. Bannister, R., D. Davis, T. Zacharewski, I. Tizard, and S. Safe. Aroclor 1254
as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: effects on enzyme induc-
tion and immunotoxicity. Toxicology 46:29-42 (1987).
9. Luster, M. I., L. I. Hong, R. Osborne, J. A. Blank, G. Clark, M. T. Silver, G.
A. Boorman, and W. F. Greenley. 1-Amino-3,7,8-trichlorodibenzo-p-dioxin:
a specific antagonist for TCDD-induced myelotoxicity. Biochem. Biophys.
Res. Commun. 139:747-756 (1986).
Antagonism by MCDF of AHH Induction 735
10. Blank, J. A., A. N. Tucker, J. Sweatlock, J. A. Gasiewicz, and M. I. Luster.
a-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-in-
duced murine lymphocyte ethoxyresorufin O-deethylase activity and immu-
nosuppression. Mo!. PharmacoL 32:168-172 (1987).
11. Astroff, B. T., Zacharewski, S. Safe, M. P. Arlotto, A. Parkinson, P. Thomas,
and W. Levin. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome
P-450 isozymes and related monooxygenase activities. MoL PharmacoL
33:231-236 (1988).
12. Lowry, 0. H., N. J. Rosebrough, A. L Farr, and B.. J. Randall. Protein
measurement with the Folin phenol reagent. J. BiOL Chem. 193:265-275
(1951).
13. Labarca, C., and K. Paigen. A simple and rapid DNA assay procedure. AnaL
Biochem. 344:344-352 (1980).
14. Nebert, D. W., and H. V. Gelboin. Substrate-inducible microsomal aryl
hydroxylase in mammalian cell culture: assay and properties of induced
enzyme. J. BiOL Chem. 242:6242-6249 (1968).
15. Pohl, R. J., and J. R. Fouts. A rapid method for assaying the metabolism of
7-ethoxyresorufin by microsomal subcellular fractions. AnaL Biochem.
107:150-155 (1980).
16. Sloop, T. C., and G. W. Lucier. Dose-dependent elevation of Ah receptor
binding by TCDD in rat liver. ToxicoL AppL PharmacoL 88:329-337 (1987).
17. Bannister, R., L. Biegel, D. Davis, B. Astroff, and S. Safe. 6-Methyl-1,3,8-
trichlorobenzofuran (MCDF) as 2,3,7,8-tetrachlorodibenzo-p-dioxin ant.ago-
nist in C57BL/6 mice. Toxicology, 54:139-150 (1989).
18. Poland, A. P., E. Glover, J. R. Robinson, and D. W. Nebert. Genetic
expression of aryl hydrocarbon hydroxylase activity: induction of monooxy-
genase activities and cytochrome O,-450 formation by 2,3,7,8-tetrachlorodi-
benzo-p-dioxin in mice genetically “nonresponsive” to other aromatic hydro-
carbons. J. BiOL Chem. 249:5599-5605 (1974).
19. Poland, A., and E. Glover. Genetic expression of aryl hydrocarbon hydrox-
ylase by 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for a receptor mutation
in genetically non-responsive mice. MoL PharrnacoL 1 1:389-398 (1975).
20. Tukey, R. H., H. R. Hannah, M. Negishi, D. W. Nebert, and H. J. Eisen. The
Ah locus: correlation of intranuclear appearance of inducer-receptor complex
with induction of cytochrome P-450 mRNA. Cell 31:275-284 (1982).
21. Matthews, H. B., and R. L. Dedrick. Pharmacokinetics of PCBs. Annu. Rev.
PharmacoL ToxicoL 24:85-103 (1984).
22. Safe, S. Metabolism, uptake, storage and bioaccumulation of halogenated
aromatic pollutants, Haiogenated Biphenyts, Naphthalenes, Dibenzodoxins
and Related Products (R. D. Kimbrough, ed). Elsevier Press, Amsterdam,
81-107 (1980).
23. Romkes, M., J. Piskorska-Pliszczynska, and S. Safe. Effects of 2,3,7,8-
tetrachlorodibenzo-p-dioxin on hepatic and uterine estrogen receptor levels
in rats. ToxicoL AppL PharmacoL 87:306-314 (1987).
24. Romkes, M., and S. Safe. Comparative activities of 2,3,7,8-tetrachlorodi-
benzo-p-dioxin and progesterone on antiestrogens in the female rat uterus.
ToxicoL AppL PharmacoL 97:368-380 (1988).
25. Hudson, L. G., W. A. Toscano, and W. F. Greenlee. Regulation of epidermal
growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin. ToxicoL AppL PharmacoL 77:251-259 (1985).
26. Osborne, R., and W. F. Greenlee. 2,3,7,8-Tetrachlorodibenzo-p-dioxin
(TCDD) enhances terminal differentiation ofcultured human epidermal cells.
ToxicoL AppL PharmacoL 77:434-443 (1985).
27. Okey, A. B., G. P. Bondy, M. E. Mason, D. W. Nebert, C. J. Forster-Gibson,
J. Muncan, and M. J. Dufresne. Temperature-dependent cytosol-to-nucleus
translocation of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in
continuous cell culture lines. J. BiOL Chem. 255:11415-11422 (1980).
28. Safe, S. H. The aryl hydrocarbon (Ah) receptor. IS! Atlas Sci. PharmacoL
2:78-83 (1988).
29. Okey, A. B., P. Bondy, M. E. Mason, G. S. Kahl, J. Eisen, T. M. Guenthner,
and D. W. Nebert. Regulatory gene product of the Ah locus: characterization
of the cytosolic inducer-receptor complex and evidence for its nuclear trans-
location. J. BioL Chem. 254:11636-11648 (1979).
30. Denomme, M. A., B. Leece, A. Li, R. Towner, and S. Safe. Elevation of
2,3,7,8-TCDD rat hepatic receptor levels by polychlorinated biphenyls: struc.
ture-activity relationships. Biochem. PharmacoL 35:277-282 (1986).
31. Clark, H. J., E. J. Peck, J. W. Hardin, and H. Eriksson. The biology and
pharmacology of estrogen receptor binding: relationship in uterine growth,
in Receptors and Hormone Action (B. W. O’Malley and L. Birnbaumer, ads.).
Academic Press, New York, 1-31 (1978).
32. Astroff, B., and S. Safe. 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) and
related analogs as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) antagonists.
Toxicologist 8:427 (1988).
Send reprint requests to: S. Safe, Veterinary Physiology and Pharmacology,
Texas A & M University, College Station, TX 77843
